Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

VIRGINIA G KAKLAMANI

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1841235439
CMS profile
129081
Location
SAN ANTONIO, TX

General Payments · PY2018–2024

$780,486.57

  • Reported across 561 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$94,472.70

66 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $25,331.03 7
Stemline Therapeutics Inc. $18,097.63 10
Gilead Sciences, Inc. $17,049.60 10
Acerta Pharma LLC $13,794.54 17
Genentech USA, Inc. $7,897.22 5
NOVARTIS PHARMACEUTICALS CORPORATION $5,653.08 8
Eli Lilly and Company $5,600.00 2
Daiichi Sankyo Inc. $731.09 3
TerSera Therapeutics LLC $286.83 2
Regeneron Healthcare Solutions, Inc. $17.02 1
Tempus AI, Inc $14.66 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $85,665.41 77
PY2019 $155,979.62 125
PY2020 $103,066.07 67
PY2021 $140,670.39 93
PY2022 $114,557.45 76
PY2023 $86,074.93 57
PY2024 $94,472.70 66

Payment records · PY2024 (66)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $1,370.00 01/04/2024 Consulting Fee Undisputed 01/23/2026 1104564976 CMS
AstraZeneca Pharmaceuticals LP $1,370.00 01/05/2024 Consulting Fee Undisputed 01/23/2026 1105547761 CMS
AstraZeneca Pharmaceuticals LP $21.86 01/08/2024 Food and Beverage Undisputed 01/23/2026 1105548111 CMS
AstraZeneca Pharmaceuticals LP $21.18 01/17/2024 Food and Beverage Undisputed 01/23/2026 1104768640 CMS
AstraZeneca Pharmaceuticals LP $2.51 01/17/2024 Food and Beverage Undisputed 01/23/2026 1105663358 CMS
AstraZeneca Pharmaceuticals LP $250.00 01/30/2024 Grant Undisputed 01/23/2026 1104527466 CMS
AstraZeneca Pharmaceuticals LP $2,750.00 02/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104338716 CMS
AstraZeneca Pharmaceuticals LP $685.00 05/07/2024 Consulting Fee Undisputed 01/23/2026 1104212587 CMS
AstraZeneca Pharmaceuticals LP $21.78 05/10/2024 Food and Beverage Undisputed 01/23/2026 1105885345 CMS
AstraZeneca Pharmaceuticals LP $685.00 05/21/2024 Consulting Fee Undisputed 01/23/2026 1105856658 CMS
AstraZeneca Pharmaceuticals LP $1,370.00 07/06/2024 Consulting Fee Undisputed 01/23/2026 1105807450 CMS
AstraZeneca Pharmaceuticals LP $21.92 07/24/2024 Food and Beverage Undisputed 01/23/2026 1105696938 CMS
AstraZeneca Pharmaceuticals LP $125.00 08/29/2024 Food and Beverage Undisputed 01/23/2026 1105659580 CMS
AstraZeneca Pharmaceuticals LP $2,750.00 09/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105393472 CMS
AstraZeneca Pharmaceuticals LP $25.29 10/22/2024 Food and Beverage Undisputed 01/23/2026 1105842493 CMS
AstraZeneca Pharmaceuticals LP $1,640.00 10/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105502380 CMS
AstraZeneca Pharmaceuticals LP $685.00 11/21/2024 Consulting Fee Undisputed 01/23/2026 1104540190 CMS
Daiichi Sankyo Inc. $28.17 05/06/2024 Food and Beverage Undisputed 01/23/2026 1089439801 CMS
Daiichi Sankyo Inc. $685.00 07/31/2024 Consulting Fee Undisputed 01/23/2026 1089439799 CMS
Daiichi Sankyo Inc. $17.92 10/14/2024 Food and Beverage Undisputed 01/23/2026 1089439797 CMS
Eli Lilly and Company $800.00 05/09/2024 Consulting Fee Undisputed 01/23/2026 1135509318 CMS
Eli Lilly and Company $4,800.00 11/07/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1135452507 CMS
Genentech USA, Inc. $6,840.00 03/14/2024 Consulting Fee Undisputed 01/23/2026 1133130449 CMS
Genentech USA, Inc. $336.55 03/14/2024 Travel and Lodging Undisputed 01/23/2026 1133130453 CMS
Genentech USA, Inc. $436.29 03/14/2024 Travel and Lodging Undisputed 01/23/2026 1133130457 CMS
Genentech USA, Inc. $75.66 03/14/2024 Travel and Lodging Undisputed 01/23/2026 1133130461 CMS
Genentech USA, Inc. $208.72 03/14/2024 Food and Beverage Undisputed 01/23/2026 1133130465 CMS
Gilead Sciences, Inc. $2,400.00 05/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133608638 CMS
Gilead Sciences, Inc. $1,980.00 06/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133608630 CMS
Gilead Sciences, Inc. $1,980.00 06/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133608632 CMS
Gilead Sciences, Inc. $143.71 09/19/2024 Food and Beverage Undisputed 01/23/2026 1133832712 CMS
Gilead Sciences, Inc. $5,140.00 09/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133608634 CMS
Gilead Sciences, Inc. $112.56 09/24/2024 Travel and Lodging Undisputed 01/23/2026 1133870050 CMS
Gilead Sciences, Inc. $18.34 11/06/2024 Food and Beverage Undisputed 01/23/2026 1133832714 CMS
Gilead Sciences, Inc. $124.99 11/12/2024 Food and Beverage Undisputed 01/23/2026 1133832716 CMS
Gilead Sciences, Inc. $3,950.00 11/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133608636 CMS
Gilead Sciences, Inc. $1,200.00 12/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133608640 CMS
Lilly USA, LLC $17.57 01/24/2024 Food and Beverage Undisputed 01/23/2026 1135466580 CMS
Lilly USA, LLC $800.00 06/17/2024 Consulting Fee Undisputed 01/23/2026 1135466578 CMS
Lilly USA, LLC $8,524.50 07/12/2024 Travel and Lodging Undisputed 01/23/2026 1135452505 CMS
Lilly USA, LLC $7,800.00 07/17/2024 Consulting Fee Undisputed 01/23/2026 1135466582 CMS
Lilly USA, LLC $4,800.00 07/19/2024 Consulting Fee Undisputed 01/23/2026 1135452509 CMS
Lilly USA, LLC $188.96 08/08/2024 Travel and Lodging Undisputed 01/23/2026 1135452511 CMS
Lilly USA, LLC $3,200.00 11/20/2024 Consulting Fee Undisputed 01/23/2026 1135452513 CMS
Novartis Pharmaceuticals Corporation $83.33 01/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086963856 CMS
Novartis Pharmaceuticals Corporation $99.70 04/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086963858 CMS
Novartis Pharmaceuticals Corporation $99.70 05/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086963860 CMS
Novartis Pharmaceuticals Corporation $2,531.25 05/31/2024 Consulting Fee Undisputed 01/23/2026 1086963852 CMS
Novartis Pharmaceuticals Corporation $98.77 05/31/2024 Food and Beverage Undisputed 01/23/2026 1086963854 CMS
Novartis Pharmaceuticals Corporation $40.33 08/13/2024 Food and Beverage Undisputed 01/23/2026 1086963850 CMS
Novartis Pharmaceuticals Corporation $1,350.00 10/24/2024 Consulting Fee Undisputed 01/23/2026 1086963862 CMS
Novartis Pharmaceuticals Corporation $1,350.00 11/20/2024 Consulting Fee Undisputed 01/23/2026 1086963864 CMS
Regeneron Healthcare Solutions, Inc. $17.02 11/15/2024 Education Undisputed 01/23/2026 1114080769 CMS
Stemline Therapeutics Inc. $3,900.00 01/12/2024 Consulting Fee Undisputed 01/23/2026 1142965742 CMS
Stemline Therapeutics Inc. $2,535.00 02/02/2024 Consulting Fee Undisputed 01/23/2026 1142965746 CMS
Stemline Therapeutics Inc. $2,340.00 02/23/2024 Consulting Fee Undisputed 01/23/2026 1142965749 CMS
Stemline Therapeutics Inc. $390.00 04/12/2024 Consulting Fee Undisputed 01/23/2026 1142965753 CMS
Stemline Therapeutics Inc. $1,560.00 05/20/2024 Consulting Fee Undisputed 01/23/2026 1142965764 CMS
Stemline Therapeutics Inc. $2,340.00 06/28/2024 Consulting Fee Undisputed 01/23/2026 1142965756 CMS
Stemline Therapeutics Inc. $429.70 06/28/2024 Honoraria Undisputed 01/23/2026 1142965760 CMS
Stemline Therapeutics Inc. $2,340.00 06/28/2024 Consulting Fee Undisputed 01/23/2026 1142965776 CMS
Stemline Therapeutics Inc. $2,145.00 11/12/2024 Consulting Fee Undisputed 01/23/2026 1142965773 CMS
Stemline Therapeutics Inc. $117.93 12/09/2024 Food and Beverage Undisputed 01/23/2026 1142965768 CMS
Tempus AI, Inc $14.66 06/21/2024 Food and Beverage Undisputed 01/23/2026 1150167166 CMS
TerSera Therapeutics LLC $12.33 05/08/2024 Food and Beverage Undisputed 01/23/2026 1144719138 CMS
TerSera Therapeutics LLC $274.50 09/01/2024 Consulting Fee Undisputed 01/23/2026 1144719140 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.